209 related articles for article (PubMed ID: 29419435)
1. Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.
Parikh SA; Chaffee KG; Larson MC; Hampel PJ; Call TG; Ding W; Kenderian SS; Leis JF; Chanan-Khan AA; Conte MJ; Bowen D; Schwager SM; Slager SL; Hanson CA; Kay NE; Shanafelt TD
Haematologica; 2018 Jun; 103(6):e237-e240. PubMed ID: 29419435
[No Abstract] [Full Text] [Related]
2. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA
Blood; 2009 Apr; 113(18):4188-96. PubMed ID: 19015397
[TBL] [Abstract][Full Text] [Related]
3. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
Scarfò L; Ghia P
Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
[TBL] [Abstract][Full Text] [Related]
4. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome.
Criado I; Rodríguez-Caballero A; Gutiérrez ML; Pedreira CE; Alcoceba M; Nieto W; Teodosio C; Bárcena P; Romero A; Fernández-Navarro P; González M; Almeida J; Orfao A;
Haematologica; 2018 Jul; 103(7):1198-1208. PubMed ID: 29567775
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
[TBL] [Abstract][Full Text] [Related]
6. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?
Angelillo P; Capasso A; Ghia P; Scarfò L
Eur J Intern Med; 2018 Dec; 58():2-6. PubMed ID: 30268574
[TBL] [Abstract][Full Text] [Related]
8. Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?
Scarfò L; Zibellini S; Tedeschi A; Maura F; Neri A; Bertazzoni P; Sarina B; Nalli G; Motta M; Rossini F; Cortelezzi A; Montillo M; Orlandi E; Ghia P
Leukemia; 2012 Jul; 26(7):1703-7. PubMed ID: 22285997
[No Abstract] [Full Text] [Related]
9. Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Winkelmann N; Rose-Zerilli M; Forster J; Parry M; Parker A; Gardiner A; Davies Z; Steele AJ; Parker H; Cross NC; Oscier DG; Strefford JC
Haematologica; 2015 Jun; 100(6):e237-9. PubMed ID: 25710457
[No Abstract] [Full Text] [Related]
10. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
[TBL] [Abstract][Full Text] [Related]
11. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.
Molica S; Mauro FR; Giannarelli D; Lauria F; Cortelezzi A; Brugiatelli M; Liso V; Cuneo A; Foà R
Haematologica; 2011 Feb; 96(2):277-83. PubMed ID: 20971821
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.
Molica S; Mauro FR; Molica M; Del Giudice I; Foà R
Leuk Lymphoma; 2012 Sep; 53(9):1660-5. PubMed ID: 22335530
[TBL] [Abstract][Full Text] [Related]
13. Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.
Criado I; Muñoz-Criado S; Rodríguez-Caballero A; Nieto WG; Romero A; Fernández-Navarro P; Alcoceba M; Contreras T; González M; Orfao A; Almeida J;
Haematologica; 2017 Jul; 102(7):1238-1246. PubMed ID: 28385786
[TBL] [Abstract][Full Text] [Related]
14. Solid organ transplant in individuals with monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
Strati P; Gharaibeh KA; Leung N; Cosio FG; Call TG; Shanafelt TD
Br J Haematol; 2016 Jul; 174(1):162-5. PubMed ID: 26436615
[No Abstract] [Full Text] [Related]
15. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.
Ojha J; Secreto C; Rabe K; Ayres-Silva J; Tschumper R; Dyke DV; Slager S; Fonseca R; Shanafelt T; Kay N; Braggio E
Leukemia; 2014 Dec; 28(12):2395-8. PubMed ID: 25034147
[No Abstract] [Full Text] [Related]
16. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics.
Nieto WG; Teodosio C; López A; Rodríguez-Caballero A; Romero A; Bárcena P; Gutierrez ML; Langerak AW; Fernandez-Navarro P; Orfao A; Almeida J;
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S24-34. PubMed ID: 20839335
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
[TBL] [Abstract][Full Text] [Related]
18. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
[TBL] [Abstract][Full Text] [Related]
19. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis.
Kleinstern G; Boddicker NJ; O'Brien DR; Allmer C; Rabe KG; Norman AD; Griffin R; Yan H; Ma T; Call TG; Bruins L; Brown S; Bonolo de Campos C; Hanson CA; Leis JF; Ding W; Vachon CM; Kay NE; Oakes CC; Parker AS; Brander DM; Weinberg JB; Furman RR; Shanafelt TD; Cerhan JR; Parikh SA; Braggio E; Slager SL
Blood Adv; 2024 May; 8(9):2118-2129. PubMed ID: 38359367
[TBL] [Abstract][Full Text] [Related]
20. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.
Fung SS; Hillier KL; Leger CS; Sandhu I; Vickars LM; Galbraith PF; Li CH; Leitch HA
Leuk Lymphoma; 2007 Jun; 48(6):1087-91. PubMed ID: 17577771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
